Regulatory compliance
The TGA monitors and enforces regulatory compliance in relation to therapeutic goods. This supports consumer protection and a fair market for industry.
Latest alerts
-
MAXMAN tablets pose a serious risk to your health and should not be taken.
-
Gold Max Blue capsules pose a serious risk to your health and should not be taken.
-
African Vigorous Max Strength poses a serious risk to your health and should not be taken.
Latest articles
-
Consent relating to listed medicines that contain whole live microorganisms as an active ingredient
This consent is given under sections 14 and 14A of the Therapeutic Goods Act 1989. -
Recall reforms update and new procedure
Recall reforms program update and preview of the PRAC Version 1.0. -
Sunshine Coast business fined over $37k for alleged unlawful sale of vapes
We have issued infringement notices totalling $37,560 for the alleged unlawful possession of a commercial quantity of vaping goods.
Latest publications
-
This plan outlines our compliance and education priorities for 2024-2025.
-
This fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.
-
Overview of therapeutic goods advertising complaints handling and compliance for 2022-23